why choose us

Clinical Trials Search

Showing 8,620 of 132,366 result(s)
External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea

Status: Completed

Condition: Microscopic Colitis

Interventions:

Date: 2023-08-28

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects and Patients With Postbariatric Hypoglycemia

Status: Completed

Condition: Healthy

Interventions: Single Ascending subcutaneous (SC) dose of MBX 1416: 10mg, 30 mg,100mg, 200mg

Date: 2023-08-28

J-Valve TF Early Feasibility Study

Status: Completed

Condition: Aortic Valve Disease

Interventions: The J-Valve TF System is a transcatheter aortic valve replacement system that consists of the J-Valve TF Bioprosthesis, J-Valve TF Delivery Device, an

Date: 2023-08-28

Redesigning Pediatric Primary Care Obesity Treatment: Virtual House Calls

Status: Completed

Condition: Obesity, Pediatric

Interventions:

Dyads first session will be 60-minutes, totaling 1 hour.
Dyads will participate in weekly 30-minute sessions for weeks 2-12, totaling 5.5 hour

Date: 2023-08-28

The MARY-JANE Cannabis and Heart Rhythm Trial

Status: NOT_YET_RECRUITING

Condition: Premature Atrial Contractions

Interventions:

Behavioral: Start: On Cannabis- In this two-day block, participants will be instructed to consume cannabis for one day and avoid cannabis the next

Date: 2023-08-28

Parent Intervention to Improve Child Sleep

Status: COMPLETED

Condition: Sleep

Interventions: The sleep intervention focuses on enhancing young children's sleep by providing parents with behavioral strategies and support.
Intervention

Date: 2023-08-28

Evaluation of Perfusion Index Change Post Passive Leg Raising for Fluid Responsiveness in Critically Ill

Status: COMPLETED

Condition: Fluid Responsiveness

Interventions:

Date: 2023-08-28

Evaluation of Perfusion Index Change Post Passive Leg Raising for Fluid Responsiveness in Critically Ill

Status: COMPLETED

Condition: Fluid Responsiveness

Interventions:

Date: 2023-08-28

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects

Status: COMPLETED

Condition: Postbariatric Hypoglycemia

Interventions: Single Ascending subcutaneous (SC) dose of MBX 1416: 10mg, 30mg,100mg, 200mg

Date: 2023-08-28

Contralateral Study of WaveLight® Femtosecond Laser Devices for Corneal Flap Creation

Status: COMPLETED

Condition: Refractive Errors

Interventions: Stationary scanning spot femtosecond laser used for corneal flap creation during refractive surgery

Date: 2023-08-28